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Salmonella is an important zoonotic pathogen and remains the primary cause of reported 
food poisoning worldwide with massive outbreaks, being S. enteritidis the most commonly reported 
serovar. The increased resistance of Salmonella to antibiotics and other biocides has encouraged the 
development of alternatives to chemotherapy. 
Bacteriophages have been proved to have the ability to provide a natural, nontoxic, feasible 
and non-expensive control of Salmonella. In the scope of the European project Phagevet-P a 
Salmonella phage belonging to the Myoviridae family was isolated from a Germany (Regensburg) 
wastewater plant. This phage named PVP-SE-1 (previously named phage 2/2) is characterised by 
having a broad lytic spectrum being able to infect different Salmonella serotypes of different countries 
and different origins (food, environmental and clinical). 
  A major concern in the use of bacteriophages as biocontrol agents is their safety. As 
bacteriophages are amplified in their pathogenic hosts, the resultant phage product might be toxic 
unless efficient and adequate downstream techniques are applied. This requires a strict product 
control and usually high production costs. The use of a non-pathogenic host would eliminate the risk 
of introducing a pathogen (and possible endotoxins) in the product, increasing its safety and reducing 
costs once stringent effectiveness of separation and filtration processes is not required. The work 
summarised herein explores this possibility by characterising and comparing the lytic performance of 
PVP-SE-1 amplified in its respective host (a pathogenic Salmonella strain) and in a non pathogenic E. 
coli strain (E. coli BL21). 
The lytic spectra of this phage replicated in BL21 and in its original Salmonella host showed 
to be the same. Additionally, latency period and burst size were determined allowing for the 
comparison of the phages replicated in the two different hosts. 
The results support the possibility of employing E. coli BL21 to produce PVP-SE-1 to be used 
as a biocontrol agent against Salmonella. 
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